Augusta, GEORGIA2 Active Studies

Geographic Atrophy Clinical Trials in Augusta, GEORGIA

Find 2 actively recruiting geographic atrophy clinical trials in Augusta, GEORGIA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
660
Enrolling

Recruiting Geographic Atrophy Studies in Augusta

About Geographic Atrophy Clinical Trials in Augusta

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 2 geographic atrophy clinical trials recruiting participants in Augusta, GEORGIA. These studies are seeking a combined 660 participants. Research is being sponsored by Mundipharma Research Limited, Calliditas Therapeutics AB. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Augusta — FAQ

Are there geographic atrophy clinical trials in Augusta?

Yes, there are 2 geographic atrophy clinical trials currently recruiting in Augusta, GEORGIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Augusta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Augusta research site will contact you about next steps.

Are clinical trials in Augusta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Augusta studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 2 active trials in Augusta are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated March 2, 2026 from ClinicalTrials.gov